Literature DB >> 22372613

Immune reconstitution to cytomegalovirus following partially matched-related donor transplantation: impact of in vivo T-cell depletion and granulocyte colony-stimulating factor-primed peripheral blood/bone marrow mixed grafts.

X-H Luo1, X-J Huang, D Li, K-Y Liu, L-P Xu, D-H Liu.   

Abstract

Cytomegalovirus (CMV) infection and delayed immune reconstitution remains a serious obstacle for successful partially matched-related donor transplantation (PMRD). We evaluated 42 patients for the development of CMV-specific CD8+ T lymphocytes (CTL(CMV) ) following granulocyte colony-stimulating factor-primed peripheral blood (PB) and bone marrow (BM) with anti-thymocyte globulin (ATG)-based PMRD. PMRD recipients achieved a high frequency, proliferation capacity, and interferon-γ response of CTL(CMV) at 1 year post transplantation. CTL(CMV) with the central memory CD45RO+CD62L+ cell phenotype expanded in PB and BM-resident CTL(CMV) displayed distinct phenotypes when CMV was reactivated. Although the incidence of CMV reactivation was high in PMRD patients (87.67%), only 11.90% of them developed CMV disease. In conclusion, after PMRD using mixed grafts with ATG-based conditioning, immune recovery to CMV seems to be early and fast, thereby reducing the incidence of CMV disease.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22372613     DOI: 10.1111/j.1399-3062.2012.00722.x

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  7 in total

Review 1.  Advancement of human leukocyte antigen-partially matched related hematopoietic stem cell transplantation.

Authors:  Xiaodong Mo; Xiaojun Huang
Journal:  Front Med       Date:  2013-07-20       Impact factor: 4.592

2.  Haploidentical hematopoietic stem cell transplantation without in vitro T-cell-depletion for the treatment of hematologic diseases.

Authors:  Xiao-Jun Huang
Journal:  Chimerism       Date:  2013-01-01

3.  Umbilical cord blood transplantation and unmanipulated haploidentical hematopoietic SCT for pediatric hematologic malignances.

Authors:  X-D Mo; X-Y Zhao; D-H Liu; Y-H Chen; L-P Xu; X-H Zhang; H Chen; W Han; Y Wang; F-R Wang; J-Z Wang; K-Y Liu; X-J Huang
Journal:  Bone Marrow Transplant       Date:  2014-06-02       Impact factor: 5.483

Review 4.  Improving cytomegalovirus-specific T cell reconstitution after haploidentical stem cell transplantation.

Authors:  Xiao-Hua Luo; Ying-Jun Chang; Xiao-Jun Huang
Journal:  J Immunol Res       Date:  2014-04-24       Impact factor: 4.818

5.  The Detailed Kinetics of Cytomegalovirus-specific T cell Responses after Hematopoietic Stem Cell Transplantation: 1 Year Follow-up Data.

Authors:  Seongman Bae; Jiwon Jung; Sun-Mi Kim; Young-Ah Kang; Young-Shin Lee; Yong Pil Chong; Heungsup Sung; Sang-Oh Lee; Sang-Ho Choi; Yang Soo Kim; Jun Hee Woo; Jung-Hee Lee; Je-Hwan Lee; Kyoo-Hyung Lee; Sung-Han Kim
Journal:  Immune Netw       Date:  2018-01-22       Impact factor: 6.303

6.  Two dose levels of rabbit antithymocyte globulin as graft-versus-host disease prophylaxis in haploidentical stem cell transplantation: a multicenter randomized study.

Authors:  Ren Lin; Yu Wang; Fen Huang; Zhiping Fan; Shen Zhang; Ting Yang; Yajing Xu; Na Xu; Li Xuan; Jieyu Ye; Jing Sun; Xiaojun Huang; Qifa Liu
Journal:  BMC Med       Date:  2019-08-12       Impact factor: 8.775

Review 7.  CMV Infection and CMV-Specific Immune Reconstitution Following Haploidentical Stem Cell Transplantation: An Update.

Authors:  Xiao-Hua Luo; Yan Zhu; Yu-Ting Chen; Li-Ping Shui; Lin Liu
Journal:  Front Immunol       Date:  2021-10-28       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.